Foundations Investment Advisors LLC Has $1.08 Million Stake in The Cigna Group (NYSE:CI)

Foundations Investment Advisors LLC boosted its stake in The Cigna Group (NYSE:CI) by 125.6% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,116 shares of the health services provider’s stock after buying an additional 1,735 shares during the quarter. Foundations Investment Advisors LLC’s holdings in The Cigna Group were worth $1,079,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of CI. Cedar Wealth Management LLC acquired a new stake in The Cigna Group in the 1st quarter valued at $29,000. TruNorth Capital Management LLC acquired a new position in The Cigna Group in the second quarter worth $33,000. Ulland Investment Advisors LLC boosted its stake in The Cigna Group by 2,500.0% in the third quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider’s stock worth $36,000 after purchasing an additional 100 shares in the last quarter. Thurston Springer Miller Herd & Titak Inc. acquired a new position in The Cigna Group in the second quarter worth $66,000. Finally, Private Ocean LLC boosted its stake in The Cigna Group by 29.9% in the second quarter. Private Ocean LLC now owns 200 shares of the health services provider’s stock worth $66,000 after purchasing an additional 46 shares in the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

The Cigna Group Trading Up 0.0 %

NYSE CI opened at $317.61 on Thursday. The stock has a 50-day simple moving average of $349.85 and a 200 day simple moving average of $343.40. The company has a market capitalization of $90.22 billion, a PE ratio of 26.08, a P/E/G ratio of 1.05 and a beta of 0.50. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.73. The Cigna Group has a 12 month low of $253.95 and a 12 month high of $370.83.

The Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, August 1st. The health services provider reported $6.72 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.42 by $0.30. The Cigna Group had a return on equity of 17.83% and a net margin of 1.70%. The company had revenue of $60.52 billion during the quarter, compared to the consensus estimate of $58.30 billion. During the same period in the prior year, the company earned $6.13 earnings per share. The company’s revenue for the quarter was up 24.6% compared to the same quarter last year. Research analysts forecast that The Cigna Group will post 28.48 EPS for the current year.

The Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 19th. Shareholders of record on Wednesday, December 4th will be issued a $1.40 dividend. This represents a $5.60 annualized dividend and a dividend yield of 1.76%. The Cigna Group’s dividend payout ratio (DPR) is currently 45.98%.

Analyst Upgrades and Downgrades

CI has been the topic of a number of recent analyst reports. Stephens reissued an “overweight” rating and issued a $410.00 price objective on shares of The Cigna Group in a research note on Friday, August 2nd. JPMorgan Chase & Co. boosted their price objective on The Cigna Group from $435.00 to $438.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 21st. Jefferies Financial Group boosted their target price on The Cigna Group from $402.00 to $422.00 and gave the stock a “buy” rating in a research report on Tuesday, September 17th. Barclays boosted their target price on The Cigna Group from $393.00 to $405.00 and gave the stock an “overweight” rating in a research report on Friday, August 2nd. Finally, Royal Bank of Canada restated an “outperform” rating and set a $384.00 target price on shares of The Cigna Group in a research report on Monday, September 9th. One investment analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Buy” and a consensus price target of $392.79.

Insiders Place Their Bets

In other The Cigna Group news, Director William J. Delaney III sold 2,691 shares of the stock in a transaction dated Monday, August 19th. The stock was sold at an average price of $342.68, for a total value of $922,151.88. Following the completion of the sale, the director now directly owns 17,539 shares in the company, valued at $6,010,264.52. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 0.60% of the company’s stock.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.